Laboratory Validation for Hereditary Tyrosinemia 1 (HT1)
Stage 1 of Hereditary Tyrosinaemia 1 implementation: Laboratory validation and verification of non-derivatised MSMS kits for use when screening for HT1 using succinylacetone measurement in dried blood spot samples in 3 laboratories.
Buyer
NHS England
Value
£56,490
Published
23 Apr 2024
Closes
31 Dec 2023
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Direct
Category
Services
Contract starts
1 Feb 2024
Contract ends
31 Jul 2024
CPV classifications
85111810
Blood analysis services
Lots
Lot default Laboratory Validation for Hereditary Tyrosinemia 1 (HT1)
£28,245
Stage 1 of Hereditary Tyrosinaemia 1 implementation: Laboratory validation and verification of non-derivatised MSMS kits for use when screening for HT1 using succinylacetone measurement in dried blood spot samples in 3 laboratories.
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
23 Apr 2024
Awarded contract notice on Contracts Finder
Award notice · Web page
Awarded contract notice on Contracts Finder
23 Apr 2024
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.